US FDA Wants More Examples Of Real-World Data Use
CDER Director Woodcock says for regulatory purposes, using real-world data likely will remain a case-by-case decision.
CDER Director Woodcock says for regulatory purposes, using real-world data likely will remain a case-by-case decision.